Ad is loading...
GXXY
Price
$0.02
Change
-$0.01 (-33.33%)
Updated
Nov 15 closing price
HLBBF
Price
$6.10
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
Ad is loading...

GXXY vs HLBBF

Header iconGXXY vs HLBBF Comparison
Open Charts GXXY vs HLBBFBanner chart's image
GALEXXY
Price$0.02
Change-$0.01 (-33.33%)
Volume$70K
CapitalizationN/A
H. Lundbeck A/S
Price$6.10
Change-$0.00 (-0.00%)
Volume$108
CapitalizationN/A
GXXY vs HLBBF Comparison Chart
Loading...
View a ticker or compare two or three
VS
GXXY vs. HLBBF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GXXY is a Hold and HLBBF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (GXXY: $0.02 vs. HLBBF: $6.10)
Brand notoriety: GXXY and HLBBF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GXXY: 276% vs. HLBBF: 12%
Market capitalization -- GXXY: $0 vs. HLBBF: $4.85B
GXXY [@Pharmaceuticals: Other] is valued at $0. HLBBF’s [@Pharmaceuticals: Other] market capitalization is $4.85B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GXXY’s FA Score shows that 1 FA rating(s) are green whileHLBBF’s FA Score has 0 green FA rating(s).

  • GXXY’s FA Score: 1 green, 4 red.
  • HLBBF’s FA Score: 0 green, 5 red.
According to our system of comparison, GXXY is a better buy in the long-term than HLBBF.

Price Growth

GXXY (@Pharmaceuticals: Other) experienced а -35.14% price change this week, while HLBBF (@Pharmaceuticals: Other) price change was -9.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
HLBBF YTD gains are higher at: 27.083 vs. GXXY (-56.000).
GXXYHLBBFGXXY / HLBBF
CapitalizationN/A4.85B-
EBITDAN/A2.94B-
Gain YTD-56.00027.083-207%
P/E RatioN/A13.25-
RevenueN/A18.9B-
Total CashN/A2.88B-
Total DebtN/A5.22B-
FUNDAMENTALS RATINGS
GXXY: Fundamental Ratings
GXXY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRSGX21.10-0.19
-0.89%
MFS Research International R1
BFONX25.43-0.53
-2.04%
Biondo Focus Investor
SUHIX44.85-0.97
-2.12%
DWS Health and Wellness Inst
TDEIX33.69-0.80
-2.32%
Transamerica US Growth I
GISTX34.76-0.90
-2.52%
Goldman Sachs Technology Opps Inv

GXXY and

Correlation & Price change

A.I.dvisor tells us that GXXY and MILFF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GXXY and MILFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GXXY
1D Price
Change %
GXXY100%
-35.14%
MILFF - GXXY
22%
Poorly correlated
N/A
TEVJF - GXXY
21%
Poorly correlated
-8.21%
MEDIF - GXXY
20%
Poorly correlated
-1.64%
CRDL - GXXY
20%
Poorly correlated
-2.15%
CHBRF - GXXY
15%
Poorly correlated
N/A
More

HLBBF and

Correlation & Price change

A.I.dvisor tells us that HLBBF and HYEX have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLBBF and HYEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLBBF
1D Price
Change %
HLBBF100%
N/A
HYEX - HLBBF
21%
Poorly correlated
N/A
HLUBF - HLBBF
18%
Poorly correlated
N/A
HLN - HLBBF
10%
Poorly correlated
+0.86%
HLNCF - HLBBF
8%
Poorly correlated
+1.13%
GXXY - HLBBF
4%
Poorly correlated
-35.14%
More